Clinical Trials Browser

Completed × Interventional × Ascites × Clear all

Ascites, Gastrointestinal Neoplasms, Ovarian Neoplasms

NCT02799212 2025-10-03

SOMAPROTECT01

Phase 3 Completed

179 enrolled

Gastrointestinal

Ascites, Carcinoma, Hepatocellular

NCT00326885 2018-10-17

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Phase 2 Completed

32 enrolled 12 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Ascites, Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

NCT02638051 2017-05-19

OTMA-RII

Phase 2 Completed

260 enrolled 13 charts

Gynecologic

Ascites, Peritoneal Neoplasms, Yin Deficiency, Yang Deficiency

NCT00327444 2013-01-01

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Phase 2/3 Completed

58 enrolled 11 charts

Gynecologic

Ascites, Ovarian Neoplasms

NCT01150916 2012-12-20

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Phase NA Completed

278 enrolled

Ascites, Carcinoma, Heart Failure, Liver Cirrhosis

NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

4 enrolled 8 charts

Thoracic

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

Clinical Trials

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

SOMAPROTECT01

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

OTMA-RII

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis